Prudential Financial Inc Aerie Pharmaceuticals Inc Transaction History

Prudential Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$6.37 - $15.23 $376,084 - $899,179	59,040 New	59,040 $894,000
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $194,782 - $360,446	-39,350 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.64 - $9.8 $1.37 Million - $2.38 Million	-242,650 Reduced 86.05%	39,350 $358,000
Q3 2019 Nov 13, 2019	BUY	$18.41 - $28.0 $1.86 Million - $2.83 Million	100,989 Added 55.79%	282,000 $5.42 Million
Q2 2019 Aug 08, 2019	BUY	$28.97 - $48.21 $2.32 Million - $3.86 Million	80,140 Added 79.45%	181,011 $0
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $2.07 Million - $2.81 Million	-57,090 Reduced 36.14%	100,871 $0
Q4 2018 Feb 07, 2019	BUY	$33.0 - $60.04 $1.51 Million - $2.75 Million	45,860 Added 40.91%	157,961 $5.7 Million
Q3 2018 Nov 07, 2018	BUY	$56.15 - $73.9 $3.61 Million - $4.76 Million	64,360 Added 134.81%	112,101 $0
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $486,586 - $716,406	-10,169 Reduced 17.56%	47,741 $0
Q1 2018 May 04, 2018	BUY	$51.15 - $61.0 $250,123 - $298,290	4,890 Added 9.22%	57,910 $0
Q4 2017 Feb 13, 2018	SELL	$50.85 - $65.1 $177,975 - $227,849	-3,500 Reduced 6.19%	53,020 $3.28 Million
Q3 2017 Nov 02, 2017	BUY	$48.6 - $60.1 $2.75 Million - $3.4 Million	56,520	56,520 $2.75 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.